Director, Clinical Pharmacology jobs in United States
cer-icon
Apply on Employer Site
company-logo

Triveni Bio · 1 day ago

Director, Clinical Pharmacology

Triveni Bio is breaking new ground in the identification of novel disease targets, focusing on precision medicine. As Director of Clinical Pharmacology, you will lead the design and execution of clinical pharmacology strategies across multiple programs, serving as a subject matter expert and collaborating with cross-functional teams to ensure compliance with regulatory standards.

BiotechnologyHealth CareMedicalTherapeutics

Responsibilities

Define and implement clinical pharmacology strategies across multiple programs
Lead PK/PD modeling, dose selection, and bioanalytical planning
Author and review clinical pharmacology sections of protocols, regulatory documents, and submissions
Collaborate with Clinical Development, Research, Regulatory Affairs, Biostatistics, and Clinical Operations to ensure integrated plans
Represent Clinical Pharmacology in governance committees and regulatory interactions
Oversee vendor management for bioanalytical and modeling activities
Ensure adherence to GCP, ICH guidelines, and all applicable regulatory requirements
Other duties as assigned

Qualification

Clinical PharmacologyPharmacokinetics (PK)Pharmacodynamics (PD)Biologics ExperienceRegulatory RequirementsVendor ManagementLeadership ExperienceCross-functional Team Management

Required

Advanced degree (PhD, PharmD, or MD) in Clinical Pharmacology or related discipline required
10+ years of experience in clinical pharmacology within the biopharmaceutical industry
Strong understanding of global regulatory requirements for clinical pharmacology
Leadership experience managing cross-functional teams and external vendors

Preferred

Experience with biologics and immunology/inflammation indications strongly preferred

Benefits

Competitive target bonus
Equity
Comprehensive benefits package

Company

Triveni Bio

twittertwitter
company-logo
Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.

Funding

Current Stage
Growth Stage
Total Funding
$207M
Key Investors
Goldman Sachs Alternatives
2024-10-02Series B· $115M
2023-10-26Series A· $92M

Leadership Team

leader-logo
Bhaskar Srivastava
Chief Medical Officer
linkedin
Company data provided by crunchbase